Unexpected increase of the CA 19-9 tumour marker in patients with endometriosis

European Journal of Gynaecological Oncology

Volumn 19, Issue 5, 1998, Pages 498-500

  Matalliotakis, I ^a,c   Panidis, D ^b   Vlassis, G ^b   Neonaki, M ^a   Goumenou, A ^a   Koumantakis, E ^a  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c NONE   (Greece)

Author keywords

CA 19 9; Danazol; Endometriosis; Oncofetal antigen

Indexed keywords

CA 19-9 ANTIGEN; DANAZOL; ONCOFETAL ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; OVARY FUNCTION;

ADULT; BIOLOGICAL MARKERS; CA-19-9 ANTIGEN; DANAZOL; ENDOMETRIOSIS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; PROGNOSIS; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 0031727175     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Magnani J. J., Steplewkski Z , Koprowski H., Ginsburg V.: "Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin". Cancer Res., 1983. 43, 5489.
2. Atkinson B. F., Erust C. S., Herlyn M., Steplewskt Z., Seras H. S., Koprowski H.: "Gastrointestinal cancer-associated antigen in immunoperoxidases assay". Cancer Res., 1982, 26, 4820.
3. Hanisch G. F., Uhlenbruck G., Dienst C.: "Structure of tumor-associated carbohydrate antigen Ca 19-9 on human seminal plasma glycoproteins from healthy donors". Eur. J. Biochem., 1984, 144, 467.
4. Panidis D. K., Vlassis G. D . Papameletiou B. A., Matalliotakis J. M., Kalogeropoulos A. P.: "Ca 19-9 in seminal plasma of infertile men". Arch. of Androl., 1988, 21, 51.
5. Uhlenbruck G., Hoeller U., Heizing J., Van Mil A., Dienst C.: "Sialytated Lea blood group substances detected by the monoclonal antibody CA 19-9 in human seminal plasma and other organs". Urol. Res., 1985, 13, 223.
6. Del Villano C. B., Brennam S., Brock P.: "Radioimmuno-metric assay for a monoclone antibody-defined tumor marker. CA 19-9". Clin. Chem., 1983, 29, 549.
7. Matalliotakis I., Neonaki M., Zolindaki A , Hassan E., Georgoulias V., Koumantakis E.: "Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis". Int., J. Fertil., 1997, 42, 211.
8. Matalliotakis I., Panidis D., Vlassis G., Vavilis D., Neonaki M., Koumatakis E.: "PRL, TSH and their response to the TRH test in patients with endometriosis before, during and after treatment with danazol". Gynecol. Obstet. Invest., 1996, 42, 183.
9. Koumantakis E., Matalliotakis I., Neonaki M., Froudarakis G., Georgoulias V: "Soluble serum interleukm-2 receptor, interleukin-6 and interleukin-1 a in patients with endometriosis and in controls". Arch. Gynecol. Obstet., 1994, 255, 107.
10. Matalliotakis I., Makrigiannakis A., Karkavitsas N., Psaroudakis E., Froudarakis G., Koumantakis E.: "Use of CA-125 in the diagnosis and management of endometriosis: Influence of treatment with danazol". Int. J. Fertil., 1994, 39, 100.
11. The American Fertility Society: "Revised American Fertility Society classification of endometriosis". Fertil. Steril., 1985, 43, 351.
12. Barbieri R. L.: "CA-125 in patients with andometriosis". Fertil. Steril., 1986, 47, 767.
13. Bagshave K. D.: "Cancer drug targeting", Clin. Radiol., 1985, 36, 545.
14. Evers J. L. H.: "The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression" Fertil Steril., 1987, 47, 502.
15. Kulakov V. I., Adamyan L. V., Yarortskaya E. L., Andreeva E. N., Tkachenko E. R.: "Immunoferment analysis of CA-125. CA-19-9, CEA and laparoscopy in the treatment of severe form of genital endometriosis". J. Am. Assoc. Gynecol, Laparosc., 1994. 1.4, 18.